YOLFTbeta
Lumos Diagnostics Holdings Ltd

Lumos Diagnostics Holdings Ltd

LDX · AU · Healthcare / Medical Devices

0.07AUD-0.00 (-1.41%)

Price History

Full chart

Market Stats

Previous Close0.071
Open0.071
Day Range0.069 – 0.074
52-Week Range0.076 – 0.33
Volume697.28K
Market Cap97.17M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.54
50-Day Avg0.1075
200-Day Avg0.1728

About

Lumos Diagnostics Holdings Limited develops, manufactures, and distributes diagnostic technologies in the United States. The company offers FebriDx, a point-of-care diagnostic test for acute respiratory infections, and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Douglas Ward
  • Employees0
  • Headquarters2724 Loker Ave West, Carlsbad, CA, United States, 92010, Australia
  • Websitehttps://lumosdiagnostics.com

Leadership

  • Mr. Douglas WardCEO, MD & Director
  • Mr. Barrie LambertChief Financial Officer
  • Mr. Anthony FavaloroVice President of Quality & Operations
  • Dr. Sacha Dopheide Ph.D.Chief Technology Officer
  • Ms. Sarah GlubkaVice President of Human Resources
  • Mr. Paul KaseChief Commercial Officer
  • Ms. Tracy Weimar BA, MBACompany Secretary
  • Ms. Annie BellVice President of Medical Affairs
  • Amelia StephensGlobal Marketing and Awareness Consultant

Financials

Income Statement

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.92M4.48M5.79M18.85M11.63M10.54M11.13M12.50M13.48M
Growth (%)-+133.42%+29.32%+225.39%-38.32%-9.42%+5.66%+12.30%+7.85%
Cost of Revenue1.08M2.44M3.28M10.25M7.17M5.21M4.03M4.59M21.39M
Gross Profit839.22K2.04M2.51M8.60M4.46M5.32M7.10M7.91M-7.91M
Gross Margin43.72%45.45%43.35%45.62%38.31%50.54%63.77%63.25%-58.68%
Operating Expense2.13M4.92M13.23M19.60M28.34M11.88M14.22M15.75M6.53M
Operating Income-1.29M-2.89M-10.72M-11.00M-23.89M-6.56M-7.12M-7.84M-14.44M
Operating Margin-67.04%-64.45%-185.00%-58.35%-205.38%-62.28%-63.98%-62.74%-107.11%
EBITDA-1.23M-2.76M-10.41M-10.69M-25.67M-4.93M-5.44M-4.63M-11.84M
EBITDA Margin-64.01%-61.57%-179.73%-56.70%-220.70%-46.79%-48.84%-37.08%-87.81%
Net Income-1.27M-4.60M-9.28M-15.03M-45.72M-8.97M-8.59M-7.18M-5.06M
Net Income Margin-65.98%-102.57%-160.16%-79.72%-393.16%-85.15%-77.19%-57.46%-37.54%
R&D276.51K2.70M2.07M1.24M1.33M246.00K69.00K106.00K424.11K
R&D as % of Total Revenue14.40%60.18%35.65%6.57%11.43%2.34%0.62%0.85%3.15%
Interest Expense18.96K15.85K19.98K0172.00K371.00K975.00K20.00K2.09M
Interest Expense % of Total Revenue0.99%0.35%0.34%0.00%1.48%3.52%8.76%0.16%15.52%

Balance Sheet

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets8.89M25.40M30.28M97.99M36.94M25.42M26.84M20.81M40.74M
Total Liabilities5.91M13.74M8.12M39.71M19.05M15.92M19.73M14.65M17.88M
Total Equity2.98M11.66M22.16M58.28M17.89M9.50M7.11M6.16M22.85M
Cash243.23K3.07M850.93K44.89M7.98M3.02M6.48M1.96M15.42M
Total Debt5.13M10.43M4.11M9.57M7.19M9.79M8.06M6.99M5.94M
Net Debt4.89M7.36M3.26M-37.69M-784.00K6.77M1.58M5.03M-9.48M

Cash Flow

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-288.67K-3.03M-3.76M-10.89M-18.04M-9.64M946.00K-9.33M1.04M
Investing Cash Flow-1.68M-8.23M-6.52M-8.33M-4.36M4.31M-98.00K-53.00K-2.59M
Financing Cash Flow2.14M14.04M8.12M63.27M-10.92M652.00K2.63M5.28M15.56M
Capital Expenditure1.68M2.53M6.52M5.88M4.36M155.00K98.00K53.00K2.59M
Free Cash Flow-1.97M-5.56M-10.28M-16.77M-22.39M-9.79M848.00K-9.39M-1.56M
FCF to OCF683.23%183.31%273.48%154.03%124.15%101.61%89.64%100.57%-150.30%

Earnings

Report DateJul 1, 2021Feb 27, 2022Aug 25, 2024Nov 27, 2024Feb 26, 2025May 28, 2025Aug 27, 2025Dec 3, 2025Feb 23, 2026
EPS Estimate-0.070.000.000.000.000.000.000.000.00
EPS Actual-0.03-0.070.000.000.000.00-0.010.000.00
Surprise57.87%--------
Timing---------

Key Statistics & Ratios

Market Cap97.17M
Enterprise Value93.49M
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.37
Price / Book3.32
EPS-0.01
Book Value0.0335
Revenue (TTM)13.19M
Gross Profit (TTM)7.88M
EBITDA-13.56M
Profit Margin-37.54%
Operating Margin-107.75%
Return on Equity-34.13%
Return on Assets-28.69%
Shares Outstanding971.67M
Shares Float551.97M
Beta0.54
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 6, 20241281:1202
  • Jun 8, 2022571:530